Global Oncolytic Virus CDMO Services Market Growth (Status and Outlook) 2026-2032
The global Oncolytic Virus CDMO Services market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Oncolytic virus CDMO service is a customized service provided to customers for the development and production of oncolytic virus vectors.
Oncolytic viruses (OVs) therapy is a new approach to treating tumors, which works by directly killing tumor cells and inducing the body's immune response. However, natural oncolytic viruses have certain limitations. Therefore, various viruses need to be used as vectors to enhance or weaken viral virulence through genetic modification and introduce new functional genes to improve their oncolytic effect. Currently, herpes simplex virus, adenovirus, vaccinia virus, vesicular stomatitis virus, measles virus, mumps virus, polio virus, etc. can be used as oncolytic virus vectors. These viral vectors can target and kill different tumor cells through different genetic modification methods, achieving better oncolytic effects.
Oncolytic virus CDMO services can accelerate the R&D and production process of oncolytic viruses, provide customers with high-quality oncolytic virus products, and promote innovation in the field of tumor treatment.
United States market for Oncolytic Virus CDMO Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Oncolytic Virus CDMO Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Oncolytic Virus CDMO Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Oncolytic Virus CDMO Services players cover Recipharm (Vibalogics), IDT Biologika, FUJIFILM Diosynth Biotechnologies, Exothera, Lonza, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Oncolytic Virus CDMO Services Industry Forecast” looks at past sales and reviews total world Oncolytic Virus CDMO Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Oncolytic Virus CDMO Services sales for 2026 through 2032. With Oncolytic Virus CDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncolytic Virus CDMO Services industry.
This Insight Report provides a comprehensive analysis of the global Oncolytic Virus CDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oncolytic Virus CDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncolytic Virus CDMO Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncolytic Virus CDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncolytic Virus CDMO Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncolytic Virus CDMO Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Oncolytic virus CDMO service is a customized service provided to customers for the development and production of oncolytic virus vectors.
Oncolytic viruses (OVs) therapy is a new approach to treating tumors, which works by directly killing tumor cells and inducing the body's immune response. However, natural oncolytic viruses have certain limitations. Therefore, various viruses need to be used as vectors to enhance or weaken viral virulence through genetic modification and introduce new functional genes to improve their oncolytic effect. Currently, herpes simplex virus, adenovirus, vaccinia virus, vesicular stomatitis virus, measles virus, mumps virus, polio virus, etc. can be used as oncolytic virus vectors. These viral vectors can target and kill different tumor cells through different genetic modification methods, achieving better oncolytic effects.
Oncolytic virus CDMO services can accelerate the R&D and production process of oncolytic viruses, provide customers with high-quality oncolytic virus products, and promote innovation in the field of tumor treatment.
United States market for Oncolytic Virus CDMO Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Oncolytic Virus CDMO Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Oncolytic Virus CDMO Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Oncolytic Virus CDMO Services players cover Recipharm (Vibalogics), IDT Biologika, FUJIFILM Diosynth Biotechnologies, Exothera, Lonza, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Oncolytic Virus CDMO Services Industry Forecast” looks at past sales and reviews total world Oncolytic Virus CDMO Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Oncolytic Virus CDMO Services sales for 2026 through 2032. With Oncolytic Virus CDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncolytic Virus CDMO Services industry.
This Insight Report provides a comprehensive analysis of the global Oncolytic Virus CDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oncolytic Virus CDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncolytic Virus CDMO Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncolytic Virus CDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncolytic Virus CDMO Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncolytic Virus CDMO Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Oncolytic Herpes Simplex Virus
- Oncolytic Adenovirus
- Oncolytic Vaccinia Virus
- Others
- R&D
- Biopharmaceutical Manufacturers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Recipharm (Vibalogics)
- IDT Biologika
- FUJIFILM Diosynth Biotechnologies
- Exothera
- Lonza
- Creative Biolabs
- Takara Bio
- Libentech
- ABL
- Nabios
- Halix
- Obio Technology
- Porton Advanced
- WuXi ATU
- Genevoyager
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncolytic Virus CDMO Services Market Size (2021-2032)
2.1.2 Oncolytic Virus CDMO Services Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Oncolytic Virus CDMO Services by Country/Region (2021, 2025 & 2032)
2.2 Oncolytic Virus CDMO Services Segment by Type
2.2.1 Oncolytic Herpes Simplex Virus
2.2.2 Oncolytic Adenovirus
2.2.3 Oncolytic Vaccinia Virus
2.2.4 Others
2.2.5 Oncolytic Virus CDMO Services Market Size by Type
2.2.5.1 Oncolytic Virus CDMO Services Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Oncolytic Virus CDMO Services Market Size Market Share by Type (2021-2026)
2.3 Oncolytic Virus CDMO Services Segment by Application
2.3.1 R&D
2.3.2 Biopharmaceutical Manufacturers
2.3.3 Others
2.3.4 Oncolytic Virus CDMO Services Market Size by Application
2.3.4.1 Oncolytic Virus CDMO Services Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Oncolytic Virus CDMO Services Market Size Market Share by Application (2021-2026)
3 ONCOLYTIC VIRUS CDMO SERVICES MARKET SIZE BY PLAYER
3.1 Oncolytic Virus CDMO Services Market Size Market Share by Player
3.1.1 Global Oncolytic Virus CDMO Services Revenue by Player (2021-2026)
3.1.2 Global Oncolytic Virus CDMO Services Revenue Market Share by Player (2021-2026)
3.2 Global Oncolytic Virus CDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLYTIC VIRUS CDMO SERVICES BY REGION
4.1 Oncolytic Virus CDMO Services Market Size by Region (2021-2026)
4.2 Global Oncolytic Virus CDMO Services Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oncolytic Virus CDMO Services Market Size Growth (2021-2026)
4.4 APAC Oncolytic Virus CDMO Services Market Size Growth (2021-2026)
4.5 Europe Oncolytic Virus CDMO Services Market Size Growth (2021-2026)
4.6 Middle East & Africa Oncolytic Virus CDMO Services Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Oncolytic Virus CDMO Services Market Size by Country (2021-2026)
5.2 Americas Oncolytic Virus CDMO Services Market Size by Type (2021-2026)
5.3 Americas Oncolytic Virus CDMO Services Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncolytic Virus CDMO Services Market Size by Region (2021-2026)
6.2 APAC Oncolytic Virus CDMO Services Market Size by Type (2021-2026)
6.3 APAC Oncolytic Virus CDMO Services Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncolytic Virus CDMO Services Market Size by Country (2021-2026)
7.2 Europe Oncolytic Virus CDMO Services Market Size by Type (2021-2026)
7.3 Europe Oncolytic Virus CDMO Services Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncolytic Virus CDMO Services by Region (2021-2026)
8.2 Middle East & Africa Oncolytic Virus CDMO Services Market Size by Type (2021-2026)
8.3 Middle East & Africa Oncolytic Virus CDMO Services Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLYTIC VIRUS CDMO SERVICES MARKET FORECAST
10.1 Global Oncolytic Virus CDMO Services Forecast by Region (2027-2032)
10.1.1 Global Oncolytic Virus CDMO Services Forecast by Region (2027-2032)
10.1.2 Americas Oncolytic Virus CDMO Services Forecast
10.1.3 APAC Oncolytic Virus CDMO Services Forecast
10.1.4 Europe Oncolytic Virus CDMO Services Forecast
10.1.5 Middle East & Africa Oncolytic Virus CDMO Services Forecast
10.2 Americas Oncolytic Virus CDMO Services Forecast by Country (2027-2032)
10.2.1 United States Market Oncolytic Virus CDMO Services Forecast
10.2.2 Canada Market Oncolytic Virus CDMO Services Forecast
10.2.3 Mexico Market Oncolytic Virus CDMO Services Forecast
10.2.4 Brazil Market Oncolytic Virus CDMO Services Forecast
10.3 APAC Oncolytic Virus CDMO Services Forecast by Region (2027-2032)
10.3.1 China Oncolytic Virus CDMO Services Market Forecast
10.3.2 Japan Market Oncolytic Virus CDMO Services Forecast
10.3.3 Korea Market Oncolytic Virus CDMO Services Forecast
10.3.4 Southeast Asia Market Oncolytic Virus CDMO Services Forecast
10.3.5 India Market Oncolytic Virus CDMO Services Forecast
10.3.6 Australia Market Oncolytic Virus CDMO Services Forecast
10.4 Europe Oncolytic Virus CDMO Services Forecast by Country (2027-2032)
10.4.1 Germany Market Oncolytic Virus CDMO Services Forecast
10.4.2 France Market Oncolytic Virus CDMO Services Forecast
10.4.3 UK Market Oncolytic Virus CDMO Services Forecast
10.4.4 Italy Market Oncolytic Virus CDMO Services Forecast
10.4.5 Russia Market Oncolytic Virus CDMO Services Forecast
10.5 Middle East & Africa Oncolytic Virus CDMO Services Forecast by Region (2027-2032)
10.5.1 Egypt Market Oncolytic Virus CDMO Services Forecast
10.5.2 South Africa Market Oncolytic Virus CDMO Services Forecast
10.5.3 Israel Market Oncolytic Virus CDMO Services Forecast
10.5.4 Turkey Market Oncolytic Virus CDMO Services Forecast
10.6 Global Oncolytic Virus CDMO Services Forecast by Type (2027-2032)
10.7 Global Oncolytic Virus CDMO Services Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Oncolytic Virus CDMO Services Forecast
11 KEY PLAYERS ANALYSIS
11.1 Recipharm (Vibalogics)
11.1.1 Recipharm (Vibalogics) Company Information
11.1.2 Recipharm (Vibalogics) Oncolytic Virus CDMO Services Product Offered
11.1.3 Recipharm (Vibalogics) Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Recipharm (Vibalogics) Main Business Overview
11.1.5 Recipharm (Vibalogics) Latest Developments
11.2 IDT Biologika
11.2.1 IDT Biologika Company Information
11.2.2 IDT Biologika Oncolytic Virus CDMO Services Product Offered
11.2.3 IDT Biologika Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 IDT Biologika Main Business Overview
11.2.5 IDT Biologika Latest Developments
11.3 FUJIFILM Diosynth Biotechnologies
11.3.1 FUJIFILM Diosynth Biotechnologies Company Information
11.3.2 FUJIFILM Diosynth Biotechnologies Oncolytic Virus CDMO Services Product Offered
11.3.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.3.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.4 Exothera
11.4.1 Exothera Company Information
11.4.2 Exothera Oncolytic Virus CDMO Services Product Offered
11.4.3 Exothera Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Exothera Main Business Overview
11.4.5 Exothera Latest Developments
11.5 Lonza
11.5.1 Lonza Company Information
11.5.2 Lonza Oncolytic Virus CDMO Services Product Offered
11.5.3 Lonza Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Lonza Main Business Overview
11.5.5 Lonza Latest Developments
11.6 Creative Biolabs
11.6.1 Creative Biolabs Company Information
11.6.2 Creative Biolabs Oncolytic Virus CDMO Services Product Offered
11.6.3 Creative Biolabs Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Creative Biolabs Main Business Overview
11.6.5 Creative Biolabs Latest Developments
11.7 Takara Bio
11.7.1 Takara Bio Company Information
11.7.2 Takara Bio Oncolytic Virus CDMO Services Product Offered
11.7.3 Takara Bio Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Takara Bio Main Business Overview
11.7.5 Takara Bio Latest Developments
11.8 Libentech
11.8.1 Libentech Company Information
11.8.2 Libentech Oncolytic Virus CDMO Services Product Offered
11.8.3 Libentech Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Libentech Main Business Overview
11.8.5 Libentech Latest Developments
11.9 ABL
11.9.1 ABL Company Information
11.9.2 ABL Oncolytic Virus CDMO Services Product Offered
11.9.3 ABL Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 ABL Main Business Overview
11.9.5 ABL Latest Developments
11.10 Nabios
11.10.1 Nabios Company Information
11.10.2 Nabios Oncolytic Virus CDMO Services Product Offered
11.10.3 Nabios Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Nabios Main Business Overview
11.10.5 Nabios Latest Developments
11.11 Halix
11.11.1 Halix Company Information
11.11.2 Halix Oncolytic Virus CDMO Services Product Offered
11.11.3 Halix Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Halix Main Business Overview
11.11.5 Halix Latest Developments
11.12 Obio Technology
11.12.1 Obio Technology Company Information
11.12.2 Obio Technology Oncolytic Virus CDMO Services Product Offered
11.12.3 Obio Technology Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Obio Technology Main Business Overview
11.12.5 Obio Technology Latest Developments
11.13 Porton Advanced
11.13.1 Porton Advanced Company Information
11.13.2 Porton Advanced Oncolytic Virus CDMO Services Product Offered
11.13.3 Porton Advanced Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Porton Advanced Main Business Overview
11.13.5 Porton Advanced Latest Developments
11.14 WuXi ATU
11.14.1 WuXi ATU Company Information
11.14.2 WuXi ATU Oncolytic Virus CDMO Services Product Offered
11.14.3 WuXi ATU Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 WuXi ATU Main Business Overview
11.14.5 WuXi ATU Latest Developments
11.15 Genevoyager
11.15.1 Genevoyager Company Information
11.15.2 Genevoyager Oncolytic Virus CDMO Services Product Offered
11.15.3 Genevoyager Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Genevoyager Main Business Overview
11.15.5 Genevoyager Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncolytic Virus CDMO Services Market Size (2021-2032)
2.1.2 Oncolytic Virus CDMO Services Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Oncolytic Virus CDMO Services by Country/Region (2021, 2025 & 2032)
2.2 Oncolytic Virus CDMO Services Segment by Type
2.2.1 Oncolytic Herpes Simplex Virus
2.2.2 Oncolytic Adenovirus
2.2.3 Oncolytic Vaccinia Virus
2.2.4 Others
2.2.5 Oncolytic Virus CDMO Services Market Size by Type
2.2.5.1 Oncolytic Virus CDMO Services Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Oncolytic Virus CDMO Services Market Size Market Share by Type (2021-2026)
2.3 Oncolytic Virus CDMO Services Segment by Application
2.3.1 R&D
2.3.2 Biopharmaceutical Manufacturers
2.3.3 Others
2.3.4 Oncolytic Virus CDMO Services Market Size by Application
2.3.4.1 Oncolytic Virus CDMO Services Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Oncolytic Virus CDMO Services Market Size Market Share by Application (2021-2026)
3 ONCOLYTIC VIRUS CDMO SERVICES MARKET SIZE BY PLAYER
3.1 Oncolytic Virus CDMO Services Market Size Market Share by Player
3.1.1 Global Oncolytic Virus CDMO Services Revenue by Player (2021-2026)
3.1.2 Global Oncolytic Virus CDMO Services Revenue Market Share by Player (2021-2026)
3.2 Global Oncolytic Virus CDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLYTIC VIRUS CDMO SERVICES BY REGION
4.1 Oncolytic Virus CDMO Services Market Size by Region (2021-2026)
4.2 Global Oncolytic Virus CDMO Services Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oncolytic Virus CDMO Services Market Size Growth (2021-2026)
4.4 APAC Oncolytic Virus CDMO Services Market Size Growth (2021-2026)
4.5 Europe Oncolytic Virus CDMO Services Market Size Growth (2021-2026)
4.6 Middle East & Africa Oncolytic Virus CDMO Services Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Oncolytic Virus CDMO Services Market Size by Country (2021-2026)
5.2 Americas Oncolytic Virus CDMO Services Market Size by Type (2021-2026)
5.3 Americas Oncolytic Virus CDMO Services Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncolytic Virus CDMO Services Market Size by Region (2021-2026)
6.2 APAC Oncolytic Virus CDMO Services Market Size by Type (2021-2026)
6.3 APAC Oncolytic Virus CDMO Services Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncolytic Virus CDMO Services Market Size by Country (2021-2026)
7.2 Europe Oncolytic Virus CDMO Services Market Size by Type (2021-2026)
7.3 Europe Oncolytic Virus CDMO Services Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncolytic Virus CDMO Services by Region (2021-2026)
8.2 Middle East & Africa Oncolytic Virus CDMO Services Market Size by Type (2021-2026)
8.3 Middle East & Africa Oncolytic Virus CDMO Services Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLYTIC VIRUS CDMO SERVICES MARKET FORECAST
10.1 Global Oncolytic Virus CDMO Services Forecast by Region (2027-2032)
10.1.1 Global Oncolytic Virus CDMO Services Forecast by Region (2027-2032)
10.1.2 Americas Oncolytic Virus CDMO Services Forecast
10.1.3 APAC Oncolytic Virus CDMO Services Forecast
10.1.4 Europe Oncolytic Virus CDMO Services Forecast
10.1.5 Middle East & Africa Oncolytic Virus CDMO Services Forecast
10.2 Americas Oncolytic Virus CDMO Services Forecast by Country (2027-2032)
10.2.1 United States Market Oncolytic Virus CDMO Services Forecast
10.2.2 Canada Market Oncolytic Virus CDMO Services Forecast
10.2.3 Mexico Market Oncolytic Virus CDMO Services Forecast
10.2.4 Brazil Market Oncolytic Virus CDMO Services Forecast
10.3 APAC Oncolytic Virus CDMO Services Forecast by Region (2027-2032)
10.3.1 China Oncolytic Virus CDMO Services Market Forecast
10.3.2 Japan Market Oncolytic Virus CDMO Services Forecast
10.3.3 Korea Market Oncolytic Virus CDMO Services Forecast
10.3.4 Southeast Asia Market Oncolytic Virus CDMO Services Forecast
10.3.5 India Market Oncolytic Virus CDMO Services Forecast
10.3.6 Australia Market Oncolytic Virus CDMO Services Forecast
10.4 Europe Oncolytic Virus CDMO Services Forecast by Country (2027-2032)
10.4.1 Germany Market Oncolytic Virus CDMO Services Forecast
10.4.2 France Market Oncolytic Virus CDMO Services Forecast
10.4.3 UK Market Oncolytic Virus CDMO Services Forecast
10.4.4 Italy Market Oncolytic Virus CDMO Services Forecast
10.4.5 Russia Market Oncolytic Virus CDMO Services Forecast
10.5 Middle East & Africa Oncolytic Virus CDMO Services Forecast by Region (2027-2032)
10.5.1 Egypt Market Oncolytic Virus CDMO Services Forecast
10.5.2 South Africa Market Oncolytic Virus CDMO Services Forecast
10.5.3 Israel Market Oncolytic Virus CDMO Services Forecast
10.5.4 Turkey Market Oncolytic Virus CDMO Services Forecast
10.6 Global Oncolytic Virus CDMO Services Forecast by Type (2027-2032)
10.7 Global Oncolytic Virus CDMO Services Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Oncolytic Virus CDMO Services Forecast
11 KEY PLAYERS ANALYSIS
11.1 Recipharm (Vibalogics)
11.1.1 Recipharm (Vibalogics) Company Information
11.1.2 Recipharm (Vibalogics) Oncolytic Virus CDMO Services Product Offered
11.1.3 Recipharm (Vibalogics) Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Recipharm (Vibalogics) Main Business Overview
11.1.5 Recipharm (Vibalogics) Latest Developments
11.2 IDT Biologika
11.2.1 IDT Biologika Company Information
11.2.2 IDT Biologika Oncolytic Virus CDMO Services Product Offered
11.2.3 IDT Biologika Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 IDT Biologika Main Business Overview
11.2.5 IDT Biologika Latest Developments
11.3 FUJIFILM Diosynth Biotechnologies
11.3.1 FUJIFILM Diosynth Biotechnologies Company Information
11.3.2 FUJIFILM Diosynth Biotechnologies Oncolytic Virus CDMO Services Product Offered
11.3.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.3.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.4 Exothera
11.4.1 Exothera Company Information
11.4.2 Exothera Oncolytic Virus CDMO Services Product Offered
11.4.3 Exothera Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Exothera Main Business Overview
11.4.5 Exothera Latest Developments
11.5 Lonza
11.5.1 Lonza Company Information
11.5.2 Lonza Oncolytic Virus CDMO Services Product Offered
11.5.3 Lonza Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Lonza Main Business Overview
11.5.5 Lonza Latest Developments
11.6 Creative Biolabs
11.6.1 Creative Biolabs Company Information
11.6.2 Creative Biolabs Oncolytic Virus CDMO Services Product Offered
11.6.3 Creative Biolabs Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Creative Biolabs Main Business Overview
11.6.5 Creative Biolabs Latest Developments
11.7 Takara Bio
11.7.1 Takara Bio Company Information
11.7.2 Takara Bio Oncolytic Virus CDMO Services Product Offered
11.7.3 Takara Bio Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Takara Bio Main Business Overview
11.7.5 Takara Bio Latest Developments
11.8 Libentech
11.8.1 Libentech Company Information
11.8.2 Libentech Oncolytic Virus CDMO Services Product Offered
11.8.3 Libentech Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Libentech Main Business Overview
11.8.5 Libentech Latest Developments
11.9 ABL
11.9.1 ABL Company Information
11.9.2 ABL Oncolytic Virus CDMO Services Product Offered
11.9.3 ABL Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 ABL Main Business Overview
11.9.5 ABL Latest Developments
11.10 Nabios
11.10.1 Nabios Company Information
11.10.2 Nabios Oncolytic Virus CDMO Services Product Offered
11.10.3 Nabios Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Nabios Main Business Overview
11.10.5 Nabios Latest Developments
11.11 Halix
11.11.1 Halix Company Information
11.11.2 Halix Oncolytic Virus CDMO Services Product Offered
11.11.3 Halix Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Halix Main Business Overview
11.11.5 Halix Latest Developments
11.12 Obio Technology
11.12.1 Obio Technology Company Information
11.12.2 Obio Technology Oncolytic Virus CDMO Services Product Offered
11.12.3 Obio Technology Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Obio Technology Main Business Overview
11.12.5 Obio Technology Latest Developments
11.13 Porton Advanced
11.13.1 Porton Advanced Company Information
11.13.2 Porton Advanced Oncolytic Virus CDMO Services Product Offered
11.13.3 Porton Advanced Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Porton Advanced Main Business Overview
11.13.5 Porton Advanced Latest Developments
11.14 WuXi ATU
11.14.1 WuXi ATU Company Information
11.14.2 WuXi ATU Oncolytic Virus CDMO Services Product Offered
11.14.3 WuXi ATU Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 WuXi ATU Main Business Overview
11.14.5 WuXi ATU Latest Developments
11.15 Genevoyager
11.15.1 Genevoyager Company Information
11.15.2 Genevoyager Oncolytic Virus CDMO Services Product Offered
11.15.3 Genevoyager Oncolytic Virus CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Genevoyager Main Business Overview
11.15.5 Genevoyager Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oncolytic Virus CDMO Services Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Oncolytic Virus CDMO Services Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oncolytic Herpes Simplex Virus
Table 4. Major Players of Oncolytic Adenovirus
Table 5. Major Players of Oncolytic Vaccinia Virus
Table 6. Major Players of Others
Table 7. Oncolytic Virus CDMO Services Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Oncolytic Virus CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Oncolytic Virus CDMO Services Market Size Market Share by Type (2021-2026)
Table 10. Oncolytic Virus CDMO Services Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Oncolytic Virus CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Oncolytic Virus CDMO Services Market Size Market Share by Application (2021-2026)
Table 13. Global Oncolytic Virus CDMO Services Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Oncolytic Virus CDMO Services Revenue Market Share by Player (2021-2026)
Table 15. Oncolytic Virus CDMO Services Key Players Head office and Products Offered
Table 16. Oncolytic Virus CDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Oncolytic Virus CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Oncolytic Virus CDMO Services Market Size Market Share by Region (2021-2026)
Table 21. Global Oncolytic Virus CDMO Services Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Oncolytic Virus CDMO Services Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Oncolytic Virus CDMO Services Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Oncolytic Virus CDMO Services Market Size Market Share by Country (2021-2026)
Table 25. Americas Oncolytic Virus CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Oncolytic Virus CDMO Services Market Size Market Share by Type (2021-2026)
Table 27. Americas Oncolytic Virus CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Oncolytic Virus CDMO Services Market Size Market Share by Application (2021-2026)
Table 29. APAC Oncolytic Virus CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Oncolytic Virus CDMO Services Market Size Market Share by Region (2021-2026)
Table 31. APAC Oncolytic Virus CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Oncolytic Virus CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Oncolytic Virus CDMO Services Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Oncolytic Virus CDMO Services Market Size Market Share by Country (2021-2026)
Table 35. Europe Oncolytic Virus CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Oncolytic Virus CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Oncolytic Virus CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Oncolytic Virus CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Oncolytic Virus CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Oncolytic Virus CDMO Services
Table 41. Key Market Challenges & Risks of Oncolytic Virus CDMO Services
Table 42. Key Industry Trends of Oncolytic Virus CDMO Services
Table 43. Global Oncolytic Virus CDMO Services Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Oncolytic Virus CDMO Services Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Oncolytic Virus CDMO Services Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Oncolytic Virus CDMO Services Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Recipharm (Vibalogics) Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 48. Recipharm (Vibalogics) Oncolytic Virus CDMO Services Product Offered
Table 49. Recipharm (Vibalogics) Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Recipharm (Vibalogics) Main Business
Table 51. Recipharm (Vibalogics) Latest Developments
Table 52. IDT Biologika Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 53. IDT Biologika Oncolytic Virus CDMO Services Product Offered
Table 54. IDT Biologika Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. IDT Biologika Main Business
Table 56. IDT Biologika Latest Developments
Table 57. FUJIFILM Diosynth Biotechnologies Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 58. FUJIFILM Diosynth Biotechnologies Oncolytic Virus CDMO Services Product Offered
Table 59. FUJIFILM Diosynth Biotechnologies Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. FUJIFILM Diosynth Biotechnologies Main Business
Table 61. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 62. Exothera Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 63. Exothera Oncolytic Virus CDMO Services Product Offered
Table 64. Exothera Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Exothera Main Business
Table 66. Exothera Latest Developments
Table 67. Lonza Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 68. Lonza Oncolytic Virus CDMO Services Product Offered
Table 69. Lonza Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Lonza Main Business
Table 71. Lonza Latest Developments
Table 72. Creative Biolabs Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 73. Creative Biolabs Oncolytic Virus CDMO Services Product Offered
Table 74. Creative Biolabs Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Creative Biolabs Main Business
Table 76. Creative Biolabs Latest Developments
Table 77. Takara Bio Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 78. Takara Bio Oncolytic Virus CDMO Services Product Offered
Table 79. Takara Bio Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Takara Bio Main Business
Table 81. Takara Bio Latest Developments
Table 82. Libentech Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 83. Libentech Oncolytic Virus CDMO Services Product Offered
Table 84. Libentech Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Libentech Main Business
Table 86. Libentech Latest Developments
Table 87. ABL Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 88. ABL Oncolytic Virus CDMO Services Product Offered
Table 89. ABL Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. ABL Main Business
Table 91. ABL Latest Developments
Table 92. Nabios Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 93. Nabios Oncolytic Virus CDMO Services Product Offered
Table 94. Nabios Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Nabios Main Business
Table 96. Nabios Latest Developments
Table 97. Halix Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 98. Halix Oncolytic Virus CDMO Services Product Offered
Table 99. Halix Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Halix Main Business
Table 101. Halix Latest Developments
Table 102. Obio Technology Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 103. Obio Technology Oncolytic Virus CDMO Services Product Offered
Table 104. Obio Technology Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Obio Technology Main Business
Table 106. Obio Technology Latest Developments
Table 107. Porton Advanced Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 108. Porton Advanced Oncolytic Virus CDMO Services Product Offered
Table 109. Porton Advanced Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Porton Advanced Main Business
Table 111. Porton Advanced Latest Developments
Table 112. WuXi ATU Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 113. WuXi ATU Oncolytic Virus CDMO Services Product Offered
Table 114. WuXi ATU Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. WuXi ATU Main Business
Table 116. WuXi ATU Latest Developments
Table 117. Genevoyager Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 118. Genevoyager Oncolytic Virus CDMO Services Product Offered
Table 119. Genevoyager Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Genevoyager Main Business
Table 121. Genevoyager Latest Developments
Table 1. Oncolytic Virus CDMO Services Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Oncolytic Virus CDMO Services Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oncolytic Herpes Simplex Virus
Table 4. Major Players of Oncolytic Adenovirus
Table 5. Major Players of Oncolytic Vaccinia Virus
Table 6. Major Players of Others
Table 7. Oncolytic Virus CDMO Services Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Oncolytic Virus CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Oncolytic Virus CDMO Services Market Size Market Share by Type (2021-2026)
Table 10. Oncolytic Virus CDMO Services Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Oncolytic Virus CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Oncolytic Virus CDMO Services Market Size Market Share by Application (2021-2026)
Table 13. Global Oncolytic Virus CDMO Services Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Oncolytic Virus CDMO Services Revenue Market Share by Player (2021-2026)
Table 15. Oncolytic Virus CDMO Services Key Players Head office and Products Offered
Table 16. Oncolytic Virus CDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Oncolytic Virus CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Oncolytic Virus CDMO Services Market Size Market Share by Region (2021-2026)
Table 21. Global Oncolytic Virus CDMO Services Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Oncolytic Virus CDMO Services Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Oncolytic Virus CDMO Services Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Oncolytic Virus CDMO Services Market Size Market Share by Country (2021-2026)
Table 25. Americas Oncolytic Virus CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Oncolytic Virus CDMO Services Market Size Market Share by Type (2021-2026)
Table 27. Americas Oncolytic Virus CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Oncolytic Virus CDMO Services Market Size Market Share by Application (2021-2026)
Table 29. APAC Oncolytic Virus CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Oncolytic Virus CDMO Services Market Size Market Share by Region (2021-2026)
Table 31. APAC Oncolytic Virus CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Oncolytic Virus CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Oncolytic Virus CDMO Services Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Oncolytic Virus CDMO Services Market Size Market Share by Country (2021-2026)
Table 35. Europe Oncolytic Virus CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Oncolytic Virus CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Oncolytic Virus CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Oncolytic Virus CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Oncolytic Virus CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Oncolytic Virus CDMO Services
Table 41. Key Market Challenges & Risks of Oncolytic Virus CDMO Services
Table 42. Key Industry Trends of Oncolytic Virus CDMO Services
Table 43. Global Oncolytic Virus CDMO Services Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Oncolytic Virus CDMO Services Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Oncolytic Virus CDMO Services Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Oncolytic Virus CDMO Services Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Recipharm (Vibalogics) Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 48. Recipharm (Vibalogics) Oncolytic Virus CDMO Services Product Offered
Table 49. Recipharm (Vibalogics) Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Recipharm (Vibalogics) Main Business
Table 51. Recipharm (Vibalogics) Latest Developments
Table 52. IDT Biologika Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 53. IDT Biologika Oncolytic Virus CDMO Services Product Offered
Table 54. IDT Biologika Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. IDT Biologika Main Business
Table 56. IDT Biologika Latest Developments
Table 57. FUJIFILM Diosynth Biotechnologies Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 58. FUJIFILM Diosynth Biotechnologies Oncolytic Virus CDMO Services Product Offered
Table 59. FUJIFILM Diosynth Biotechnologies Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. FUJIFILM Diosynth Biotechnologies Main Business
Table 61. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 62. Exothera Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 63. Exothera Oncolytic Virus CDMO Services Product Offered
Table 64. Exothera Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Exothera Main Business
Table 66. Exothera Latest Developments
Table 67. Lonza Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 68. Lonza Oncolytic Virus CDMO Services Product Offered
Table 69. Lonza Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Lonza Main Business
Table 71. Lonza Latest Developments
Table 72. Creative Biolabs Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 73. Creative Biolabs Oncolytic Virus CDMO Services Product Offered
Table 74. Creative Biolabs Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Creative Biolabs Main Business
Table 76. Creative Biolabs Latest Developments
Table 77. Takara Bio Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 78. Takara Bio Oncolytic Virus CDMO Services Product Offered
Table 79. Takara Bio Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Takara Bio Main Business
Table 81. Takara Bio Latest Developments
Table 82. Libentech Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 83. Libentech Oncolytic Virus CDMO Services Product Offered
Table 84. Libentech Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Libentech Main Business
Table 86. Libentech Latest Developments
Table 87. ABL Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 88. ABL Oncolytic Virus CDMO Services Product Offered
Table 89. ABL Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. ABL Main Business
Table 91. ABL Latest Developments
Table 92. Nabios Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 93. Nabios Oncolytic Virus CDMO Services Product Offered
Table 94. Nabios Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Nabios Main Business
Table 96. Nabios Latest Developments
Table 97. Halix Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 98. Halix Oncolytic Virus CDMO Services Product Offered
Table 99. Halix Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Halix Main Business
Table 101. Halix Latest Developments
Table 102. Obio Technology Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 103. Obio Technology Oncolytic Virus CDMO Services Product Offered
Table 104. Obio Technology Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Obio Technology Main Business
Table 106. Obio Technology Latest Developments
Table 107. Porton Advanced Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 108. Porton Advanced Oncolytic Virus CDMO Services Product Offered
Table 109. Porton Advanced Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Porton Advanced Main Business
Table 111. Porton Advanced Latest Developments
Table 112. WuXi ATU Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 113. WuXi ATU Oncolytic Virus CDMO Services Product Offered
Table 114. WuXi ATU Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. WuXi ATU Main Business
Table 116. WuXi ATU Latest Developments
Table 117. Genevoyager Details, Company Type, Oncolytic Virus CDMO Services Area Served and Its Competitors
Table 118. Genevoyager Oncolytic Virus CDMO Services Product Offered
Table 119. Genevoyager Oncolytic Virus CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Genevoyager Main Business
Table 121. Genevoyager Latest Developments
LIST OF FIGURES
Figure 1. Oncolytic Virus CDMO Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncolytic Virus CDMO Services Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Oncolytic Virus CDMO Services Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Oncolytic Virus CDMO Services Sales Market Share by Country/Region (2025)
Figure 8. Oncolytic Virus CDMO Services Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Oncolytic Virus CDMO Services Market Size Market Share by Type in 2025
Figure 10. Oncolytic Virus CDMO Services in R&D
Figure 11. Global Oncolytic Virus CDMO Services Market: R&D (2021-2026) & ($ millions)
Figure 12. Oncolytic Virus CDMO Services in Biopharmaceutical Manufacturers
Figure 13. Global Oncolytic Virus CDMO Services Market: Biopharmaceutical Manufacturers (2021-2026) & ($ millions)
Figure 14. Oncolytic Virus CDMO Services in Others
Figure 15. Global Oncolytic Virus CDMO Services Market: Others (2021-2026) & ($ millions)
Figure 16. Global Oncolytic Virus CDMO Services Market Size Market Share by Application in 2025
Figure 17. Global Oncolytic Virus CDMO Services Revenue Market Share by Player in 2025
Figure 18. Global Oncolytic Virus CDMO Services Market Size Market Share by Region (2021-2026)
Figure 19. Americas Oncolytic Virus CDMO Services Market Size 2021-2026 ($ millions)
Figure 20. APAC Oncolytic Virus CDMO Services Market Size 2021-2026 ($ millions)
Figure 21. Europe Oncolytic Virus CDMO Services Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Oncolytic Virus CDMO Services Market Size 2021-2026 ($ millions)
Figure 23. Americas Oncolytic Virus CDMO Services Value Market Share by Country in 2025
Figure 24. United States Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Oncolytic Virus CDMO Services Market Size Market Share by Region in 2025
Figure 29. APAC Oncolytic Virus CDMO Services Market Size Market Share by Type (2021-2026)
Figure 30. APAC Oncolytic Virus CDMO Services Market Size Market Share by Application (2021-2026)
Figure 31. China Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 35. India Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Oncolytic Virus CDMO Services Market Size Market Share by Country in 2025
Figure 38. Europe Oncolytic Virus CDMO Services Market Size Market Share by Type (2021-2026)
Figure 39. Europe Oncolytic Virus CDMO Services Market Size Market Share by Application (2021-2026)
Figure 40. Germany Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 41. France Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Oncolytic Virus CDMO Services Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Oncolytic Virus CDMO Services Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Oncolytic Virus CDMO Services Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 54. APAC Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 55. Europe Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 57. United States Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 58. Canada Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 59. Mexico Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 60. Brazil Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 61. China Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 62. Japan Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 63. Korea Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 65. India Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 66. Australia Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 67. Germany Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 68. France Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 69. UK Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 70. Italy Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 71. Russia Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 72. Egypt Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 73. South Africa Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 74. Israel Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 75. Turkey Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 76. Global Oncolytic Virus CDMO Services Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Oncolytic Virus CDMO Services Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 1. Oncolytic Virus CDMO Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncolytic Virus CDMO Services Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Oncolytic Virus CDMO Services Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Oncolytic Virus CDMO Services Sales Market Share by Country/Region (2025)
Figure 8. Oncolytic Virus CDMO Services Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Oncolytic Virus CDMO Services Market Size Market Share by Type in 2025
Figure 10. Oncolytic Virus CDMO Services in R&D
Figure 11. Global Oncolytic Virus CDMO Services Market: R&D (2021-2026) & ($ millions)
Figure 12. Oncolytic Virus CDMO Services in Biopharmaceutical Manufacturers
Figure 13. Global Oncolytic Virus CDMO Services Market: Biopharmaceutical Manufacturers (2021-2026) & ($ millions)
Figure 14. Oncolytic Virus CDMO Services in Others
Figure 15. Global Oncolytic Virus CDMO Services Market: Others (2021-2026) & ($ millions)
Figure 16. Global Oncolytic Virus CDMO Services Market Size Market Share by Application in 2025
Figure 17. Global Oncolytic Virus CDMO Services Revenue Market Share by Player in 2025
Figure 18. Global Oncolytic Virus CDMO Services Market Size Market Share by Region (2021-2026)
Figure 19. Americas Oncolytic Virus CDMO Services Market Size 2021-2026 ($ millions)
Figure 20. APAC Oncolytic Virus CDMO Services Market Size 2021-2026 ($ millions)
Figure 21. Europe Oncolytic Virus CDMO Services Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Oncolytic Virus CDMO Services Market Size 2021-2026 ($ millions)
Figure 23. Americas Oncolytic Virus CDMO Services Value Market Share by Country in 2025
Figure 24. United States Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Oncolytic Virus CDMO Services Market Size Market Share by Region in 2025
Figure 29. APAC Oncolytic Virus CDMO Services Market Size Market Share by Type (2021-2026)
Figure 30. APAC Oncolytic Virus CDMO Services Market Size Market Share by Application (2021-2026)
Figure 31. China Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 35. India Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Oncolytic Virus CDMO Services Market Size Market Share by Country in 2025
Figure 38. Europe Oncolytic Virus CDMO Services Market Size Market Share by Type (2021-2026)
Figure 39. Europe Oncolytic Virus CDMO Services Market Size Market Share by Application (2021-2026)
Figure 40. Germany Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 41. France Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Oncolytic Virus CDMO Services Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Oncolytic Virus CDMO Services Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Oncolytic Virus CDMO Services Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Oncolytic Virus CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 54. APAC Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 55. Europe Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 57. United States Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 58. Canada Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 59. Mexico Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 60. Brazil Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 61. China Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 62. Japan Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 63. Korea Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 65. India Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 66. Australia Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 67. Germany Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 68. France Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 69. UK Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 70. Italy Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 71. Russia Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 72. Egypt Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 73. South Africa Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 74. Israel Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 75. Turkey Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
Figure 76. Global Oncolytic Virus CDMO Services Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Oncolytic Virus CDMO Services Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Oncolytic Virus CDMO Services Market Size 2027-2032 ($ millions)
